KURA
Kura Oncology Inc
Price:  
9.63 
USD
Volume:  
1,127,808.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KURA WACC - Weighted Average Cost of Capital

The WACC of Kura Oncology Inc (KURA) is 11.2%.

The Cost of Equity of Kura Oncology Inc (KURA) is 11.25%.
The Cost of Debt of Kura Oncology Inc (KURA) is 5.00%.

Range Selected
Cost of equity 9.80% - 12.70% 11.25%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 9.8% - 12.6% 11.2%
WACC

KURA WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.3 1.4
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.80% 12.70%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.01 0.01
Cost of debt 5.00% 5.00%
After-tax WACC 9.8% 12.6%
Selected WACC 11.2%